Clinical Trials Directory

Trials / Completed

CompletedNCT01249196

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
256 (estimated)
Sponsor
SK Chemicals Co., Ltd. · Industry
Sex
All
Age
55 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.

Conditions

Interventions

TypeNameDescription
DRUGSK-PC-B70Mfor dosage

Timeline

Start date
2010-05-01
Primary completion
2013-08-01
First posted
2010-11-29
Last updated
2013-11-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01249196. Inclusion in this directory is not an endorsement.

A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease (NCT01249196) · Clinical Trials Directory